Related Experiment Video
Updated: Feb 12, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes
Najmeh Ahangari1, Majid Ghayour Mobarhan2, Amirhossein Sahebkar3,4
1a Departement of Modern Sciences and Technologies, Faculty of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran.
Insights
Hypercholesterolemia affects 39% of adults. This review covers molecular insights into current and novel therapies for lowering low-density lipoprotein cholesterol (LDL-C), crucial for preventing cardiovascular disease.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Pharmacology
Background:
- Hypercholesterolemia, affecting 39% of adults, is characterized by elevated low-density lipoprotein cholesterol (LDL-C).
- Genetic mutations in LDLR, ApoB, PCSK9, and LDLRAP impair LDL receptor-mediated clearance, leading to arterial LDL deposition, atherosclerosis, and premature cardiovascular disease.
- Understanding the molecular basis is key to managing this prevalent condition.
Purpose of the Study:
- To review molecular mechanisms of hypercholesterolemia.
- To explore current and emerging therapeutic strategies for lowering LDL-C.
- To highlight the impact of genetic factors on treatment.
Main Methods:
- Literature review of molecular aspects of hypercholesterolemia.
- Analysis of current therapeutic agents including statins, ezetimibe, bile acid sequestrants, and PCSK9 inhibitors.
- Examination of novel RNA-based therapies and genetic contributions.
Main Results:
- Identified LDLR, PCSK9, and ApoB as key genes involved in hypercholesterolemia.
- Current treatments focus on LDL-C reduction through various drug classes.
- RNA-based therapies represent a significant advancement in treatment strategies.
Conclusions:
- Continued research into molecular pathways will enable more targeted hypercholesterolemia therapies.
- Integrated approaches combining lifestyle changes, disease management, and pharmacotherapy are essential.
- Pharmacogenetic considerations are vital for optimizing treatment efficacy and safety.
Abstract:
Hypercholesterolemia is a pathological condition which has been reported in 39% of the worlds' adult population. We aimed to review molecular aspects of current and novel therapeutic approaches based on low-density lipoprotein cholesterol lowering strategies. Pathogenic mutations in the LDLR, ApoB, PCSK9 and LDLRAP genes cause deficient clearance of circulating low-density lipoprotein cholesterol particles via hepatic LDL receptor. This leads to increased plasma LDL cholesterol levels from birth, which can cause LDL depositions in the arterial walls. Ultimately, it progresses to atherosclerosis and an increased risk of premature cardiovascular diseases. Currently, statins, Ezetimibe, Bile acid sequestrants and PCSK9 inhibitors are the main therapeutic agents for the treatment of hypercholesterolemia. Moreover, novel RNA-based therapy had a strong impact on therapeutic strategies in recent decades. Additional development in understanding of the molecular basis of hypercholesterolemia will provide opportunities for the development of targeted therapy in the near future. Key Messages The most common genes involved in hypercholesterolemia are LDLR, PCSK9 and ApoB. Pharmacogenetic effects are typically constrained to pathways closely related to the pharmacodynamics and pharmacokinetics. Change in lifestyle and diet along with treatment of the underlying disease and drug therapy are the current therapeutic strategies.
More Related Videos
10:56A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
07:00Acquisition of High-Quality Digital Video of Drosophila Larval and Adult Behaviors from a Lateral Perspective
Published on: October 4, 2014
Related Concept Videos
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Quantitative Aspects of Drug-Receptor Interaction
Molecular Models